ArticleOncotarget2014

Targeting CDC25C, PLK1 and CHEK1 to overcome Docetaxel resistance induced by loss of LZTS1 in prostate cancer.

Nader Al Nakouzi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.